l carnitine dialysis Practice recommendations for the use of L-Carnitine in dialysis-related disorder National Kidney Foundation Carnitine Consensus Conference Understanding the Role of Carnitine

Condies cardacas A L-carnitina tem demonstrado possveis benefcios em condies cardacas, como insuficincia cardaca, recuperao aps infarto ou cirurgia do corao, e na doena arterial perifrica

It is not a stand-alone fat burner and should not be expected to create significant changes in isolation

: 20 : 60 : , -, , , ( , ), ( , , , ),

Ethics declarations Conflict of Interest Diego Maria Michele Fornasari received fees as congress speaker or consultant from the following pharmaceutical companies: Angelini, Abiogen, Alfasigma (the manufacturer of acetyl-l-carnitine), Chiesi, Istituto Gentili, Grunentahl, Molteni, Sandoz, SPA, Viatris, Zambon

Longo N, Frigeni M, Pasquali M

Clinical Information Evidence-based details for healthcare providers Use as directed by your healthcare provider